poor prognosis phenotype

Aliases

extremely poor prognosis, poor survival outlook, worse prognosis

No related entities found.

Mentioned in (45)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Whole-genome landscapes of 1,364 breast cancers. (2026)
• Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• Chromosomal instability as a driver of cancer progression. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. (2022)
• Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology. (2021)
• Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
• Application of third-generation sequencing in cancer research. (2021)
• Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
• NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML. (2021)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Inferring structural variant cancer cell fraction. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
• How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia. (2019)
• VCF2CNA: A tool for efficiently detecting copy-number alterations in VCF genotype data and tumor purity. (2019)
• Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
• Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. (2018)
• Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• The Immune Landscape of Cancer. (2018)
• Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. (2018)
• Copy number signatures and mutational processes in ovarian carcinoma. (2018)
• Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
• Prognostic value of inflammation-based scores in patients with osteosarcoma. (2016)
• Systematic pan-cancer analysis of tumour purity. (2015)
• Hidden Markov Model-Based CNV Detection Algorithms for Illumina Genotyping Microarrays. (2014)
• Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
• A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. (2013)
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. (2013)
• Pan-cancer patterns of somatic copy number alteration. (2013)
• Myeloid cells in tumor inflammation. (2012)
• Molecular genetics of B-precursor acute lymphoblastic leukemia. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• Fewer permutations, more accurate P-values. (2009)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.